Cannabinoids are naturally occurring molecules found in cannabis that are linked to a number of medical benefits and treatments.The Cannabis Review | Cannabinoids is a collection of scientific studies that identifies the conditions cannabinoids treat, by what mechanism, the magnitude of the effect.


This is the measurement of the nature and methodology of the scientific study.

Double-blind, placebo controlled clinical study
Open clinical trial study; no control group and no blinded clinical trial
Non-human subject research on isolated cannabis compounds
Non-human subject research on cannabis compound in a mixture

Magnitude of Effect

This identifies how effective the biological activity of the cannabinoid was treating the

major Biological activity has a major effect on the condition
moderate Biological activity has an moderate effect on the condition
minor Biological activity has a minor effect on the condition

Primary Studies

The following are scientific studies that have shown the effectiveness of cannabinoids treating specific conditions.
Study names are linked to the studies, click to view.

Cannabinoid Condition Treated Effect Amount Used Study Grade
Colitis Antiinflammatory(major) NA The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis
Depression Antidepressant(major) 20mg/kg,

Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L
Edema Antiinflammatory(major) NA
Anti-inflammatory properties of cannabichromene

see more studies
Inflammation-induced hypermotility Antiinflammatory(major) 10mg/kg
Inhibitory effect of cannabichromene, a (major) non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice
Microbiological Contamination Antimicrobial(major) NA
Biological Activity of Cannabichromene, its Homologs and Isomers

see more studies
Acute lung injury Antiinflammatory(moderate) 20mg/kg
Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: Role for the adenosine A2A receptor
Acute Pancreatitis Antiinflammatory(major) 0.5mg/kg
Anti-inflammatory role of cannabidiol and O-1602 in cerulein-induced acute pancreatitis in mice
AD-related neuroinflammation Antiinflammatory(major) 2.5 or 10mg/kg
Cannabidiol in vivo blunts β-amyloid induced neuroinflammation by suppressing IL-1β and iNOS expression
Alzheimer’s Disease Neuroprotectant(moderate) NA
The marijuana component cannabidiol inhibits β-amyloid-induced tau protein hyperphosphorylation through Wnt/β-catenin pathway rescue in PC12 cells
Anorexia Appetite Stimulant(major) NA
Effects of Dronabinol on Anorexia and disturbed behavior in patients with Alzheimer’s Disease

see more studies
Anxiety Anxiolytic(major) 600mg
Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients

see more studies
Arthritis Antiarthritic(major) 5mg/kg,

The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis.
Bacterial Contamination Antibacterial(moderate) 50μg/ml
Antibacterial activity of Δ9-tetrahydrocannabinol and cannabidiol

see more studies
Brain Injury Neuroprotectant(major) 300mg
Comparison of Cannabidiol, Antioxidants, and Diuretics in Reversing Binge Ethanol-Induced Neurotoxicity

see more studies
Cancer Antitumor(major) NA
Antitumor Activity of Plant Cannabinoids with Emphasis on the Effect of Cannabidiol on Human Breast Carcinoma

see more studies
Cancer Anticancer(major) NA
The Combination of Cannabidiol and Δ9-Tetrahydrocannabinol Enhances the Anticancer Effects of Radiation in an Orthotopic Murine Glioma Model

see more studies
(Prostate Carcinoma)
Antiproliferative(moderate) 1–10µM
Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms

see more studies
Cardiovascular Complications Cardiac Proctection(major) NA
Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy
Central Neuropathic Pain Analgesic(moderate) 25mg/mL
Oromucosal Δ9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: An uncontrolled, open-label, 2-year extension trial
Chronic Pain Antiinflammatory(minor) 2.5–20mg/kg,

The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain
Depression Antidepressant(moderate) 15mg/kg,

Prohedonic Effect of Cannabidiol in a Rat Model of Depression

see more studies
Diabetic Complications Antiinflammatory(major) NA
Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption

see more studies
(Seizure state)
Anticonvulsant(major) 1mg/kg,

Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures

see more studies
Glioblastoma multiforme Anticancer(major) NA
A Combined Preclinical Therapy of Cannabinoids and Temozolomide against Glioma
Hyperlocomotion Antipsychotic(moderate) 15–60mg/kg
Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice
Immobility Antidepressant(moderate) 10–60nmol
Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex—Possible involvement of 5-HT1A and CB1 receptors
Immune System related diseases Auto-immunity(moderate) 2.5 or 5mg/kg
Cannabidiol-induced Lymphopenia does not involve NKT and NK Cells
Inflammation Antiinflammatory(moderate) 5–40mg/kg
Oral anti-inflammatory activity of cannabidiol, a non-psychoactive constituent of cannabis, in acute carrageenan-induced inflammation in the rat paw
Insomnia Improve Sleep(moderate) 25mg,
6mg to 12mg

Effectiveness of Cannabidiol Oil for Pediatric Anxiety and Insomnia as Part of Posttraumatic Stress Disorder: A Case Report
Nausea Antiemetic(moderate) 200mg/kg
Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT1A somatodendritic autoreceptors in the dorsal raphe nucleus

see more studies
Neuroinflammatory diseases Antiinflammatory(minor) NA
Anti-inflammatory effects of the cannabidiol derivative dimethylheptyl-cannabidiol – studies in BV-2 microglia and encephalitogenic T cells
Osteoporosis Bone Stimulant(moderate) NA
Regulation of bone by cannabinoid and cannabinoid-like receptors
Parkinson’s Disease Neuroprotectant(moderate) 300mg
Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial
Pathological memory T cells and in Autoimmune diseases Antiinflammatory(major) NA
Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells
Peripheral pain response Analgesic(moderate) NA
(+)-Cannabidiol analogues which bind cannabinoid receptors but exert peripheral activity only
Posttraumatic stress disorder(PTSD) Anxiolytic(moderate) NA
Cannabidiol blocks long-lasting behavioral consequences of predator threat stress: Possible involvement of 5HT1A receptors
Psychotic Experiences Antipsychotic(minor) NA
Cannabis with high cannabidiol content is associated with fewer psychotic experiences
Retinal Inflammatory Antiinflammatory(moderate) NA
Mediation of Cannabidiol Anti-inflammation in the Retina by Equilibrative Nucleoside Transporter and A2A Adenosine Receptor
Rheumatic Diseases Antiinflammatory(moderate) NA
Cannabidiol—transdermal delivery and anti-inflammatory effect in a murine model
Sepsis Antiinflammatory(minor) NA
Effect of cannabidiol on sepsis-induced motility disturbances in mice: involvement of CB1 receptors and fatty acid amide hydrolase
Spasticity Antispasticity(minor) NA
Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis
Spinal Injury Neuroprotectant(moderate) 20mg/kg
Cannabidiol-treated Rats Exhibited Higher Motor Score After Cryogenic Spinal Cord Injury
Uveitis Antiinflammatory(major) 5mg/kg
Neuroprotective effects of cannabidiol in endotoxin-induced uveitis: critical role of p38 MAPK activation
(Cannabidiolic acid)
Cancer Anticancer(moderate) NA
Cannabidiolic acid, a (major) cannabinoid in fiber-type cannabis, is an inhibitor of MDA-MB-231 breast cancer cell migration
Inflammation Antiinflammatory(minor) 2μM
Cannabidiolic Acid as a Selective Cyclooxygenase-2 Inhibitory Component in Cannabis
Nausea Antiemetic(moderate) 0.5mg/kg
Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activation

see more studies
Epilepsy Anticonvulsant(moderate) NA
Cannabis in epilepsy: From clinical practice to basic research focusing on the possible role of cannabidivarin

see more studies
Cancer Antitumor(major) N/A
Boron trifluoride etherate on silica-A modified lewis acid reagent (VII). Antitumor activity of cannabigerol against human oral epitheloid carcinoma cells

see more studies
Glaucoma Antiglaucoma(moderate) NA
A Comparison of the Ocular and Central Effects of Δ9-Tetrahydrocannabinol and Cannabigerol
Human immune diseases Immunosuppressive(moderate) NA
A Cannabigerol Derivative Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis
Huntington’s Disease Neuroprotectant(moderate) NA
Neuroprotective Properties of Cannabigerol in Huntington’s Disease: Studies in R6/2 Mice and 3-Nitropropionate-lesioned Mice

see more studies
Irritable bowel syndrome Antiinflammatory(major) NA
Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease
MRSA Antibacterial(moderate) NA
Antibacterial Cannabinoids from Cannabis sativa: A Structure−Activity Study
Neuroinflammation Antiinflammatory(moderate) NA
A Cannabigerol Quinone Alleviates Neuroinflammation in a Chronic Model of Multiple Sclerosis
Oxidative-stress related disorders Antioxidant(moderate) NA
Cannabinoid CB2 receptors are involved in the protection of RAW264.7 macrophages against the oxidative stress: an in vitro study
(Cannabigerolic Acid)
Inflammation Antiinflammatory(moderate) NA
Evaluation of the Cyclooxygenase Inhibiting Effects of Six Major Cannabinoids Isolated from Cannabis sativa.
ALS Neuroprotectant(moderate) 5mg/kg Cannabinol delays symptom onset in SOD1 (G93A) transgenic mice without affecting survival
Low feeding behaviour Appetite Stimulant(minor) NA Cannabinol and cannabidiol exert opposing effects on rat feeding patterns
MRSA Antibacterial(moderate) NA Antibacterial Cannabinoids from Cannabis sativa: A Structure−Activity Study
Pain Analgesic(major) NA Comparative analgesic activity of various naturally occurring cannabinoids in mice and rats
Tonic-clonic seizure Anticonvulsant(moderate) NA Anticonvulsant properties of Δ9-tetrahydrocannabinol and other cannabinoids
Tumor Antitumor(moderate) 100mg/kg,
Antineoplastic Activity of Cannabinoids
Acute psychosocial stress Anxiolytic(moderate) 7.5mg,
Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress
ADHD Improves behaviour(moderate) 71ng/mL Cannabis improves symptoms of ADHD
ADHD Neuroprotectant(moderate) NA Oral Δ9-Tetrahydrocannabinol Improved Refractory Gilles de la Tourette Syndrome in an Adolescent by Increasing Intracortical Inhibition: A Case Report
ALS Neuroprotectant(moderate) NA The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset
Alzheimer’s Disease Neuroprotectant(major) NA The potential therapeutic effects of THC on Alzheimer’s disease
Anorexia Appetite Stimulant(moderate) 2.5mg A phase II study of delta-9-tetrahydrocannabinol for appetite stimulation in cancer-associated anorexia
Crohn’s Disease Antiinflammatory(minor) 115mg Cannabis induces a clinical response in patients with Crohn’s disease: a prospective placebo-controlled study
Edema Antiinflammatory(minor) NA Antipyretic, analgesic and anti-inflammatory effects of Δ9-tetrahydrocannabinol in the rat
Emetic activity Antiemetic(moderate) 10mg/m2 Delta-9-tetrahydrocannabinol delays the gastric emptying of solid food in humans: a double-blind, randomized study

see more studies
Glioblastoma multiforme Anticaner(major) NA A Combined Preclinical Therapy of Cannabinoids and Temozolomide against Glioma
Immobility Antidepressant(moderate) 2.5mg/kg Antidepressant-like effect of Δ9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L
Intestinal inflammation Antiinflammatory(moderate) NA Chronic Administration of Δ9-Tetrahydrocannabinol Induces Intestinal Anti-Inflammatory MicroRNA Expression during Acute Simian Immunodeficiency Virus Infection of Rhesus Macaques
Friend leukemia virus-induced splenomegaly Antileukemic(major) 200mg/kg Antineoplastic Activity of Cannabinoids
Multiple Sclerosis Analgesic(minor) 10mg Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial
Neurological disorders Neuroprotectant(moderate) NA Cannabidiol and (−)Δ9-tetrahydrocannabinol are neuroprotective antioxidants
Neuropathic Pain Analgesic(major) 25mg Smoked cannabis for chronic neuropathic pain: a randomized controlled trial
Oxidative Stress Neuroprotectant(moderate) NA Reactive oxygen species and p38 phosphorylation regulate the protective effect of Δ9-tetrahydrocannabinol in the apoptotic response to NMDA
Oxidative Stress Antioxidant(minor) NA Understanding the Molecular Aspects of Tetrahydrocannabinol and Cannabidiol as Antioxidants
Pain Analgesic(minor) NA Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice
Pain Antinociceptive(moderate) 1mg/kg,
Dopamine D2 receptor antagonists prevent Δ9-tetrahydrocannabinol-induced antinociception in rats

see more studies
Spasticity Antispacity(minor) NA Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial
(Tetrahydrocannabinolic Acid)
Neurodegeneration Neuroprotective(moderate) 10μM Effects of cannabinoids Δ(9)-tetrahydrocannabinol, Δ(9)-tetrahydrocannabinolic acid and cannabidiol in MPP+ affected murine mesencephalic cultures
Acne Anti-acne(major) NA Differential effectiveness of selected non-psychotropic phytocannabinoids on human sebocyte functions implicates their introduction in dry/seborrhoeic skin and acne treatment
Epelipsy Anticonvulsant(moderate) 0.25mg/kg Δ9-Tetrahydrocannabivarin suppresses in vitro epileptiform and in vivo seizure activity in adult rats
Ischaemia-reperfusion (I/R) Antiinflammation(moderate) NA Δ8-Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB2 receptors
Nausea Antinausea(minor) 10mg/kg Evaluation of the potential of the phytocannabinoids, cannabidivarin (CBDV) and Δ9-tetrahydrocannabivarin (THCV), to produce CB1 receptor inverse agonism symptoms of nausea in rats
Obesity Antiobesity(moderate) NA Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients.

see more studies

Secondary Materials

The following are study reviews and other materials of note

Cannabinoid Condition Treated Effect Study
Cancer Anticancer
The endocannabinoid system and cancer: Therapeutic implication
Depression(causes Insomnia and pain interactions) Antidepressant
Review Article: Sleep, Pain and Cannabis
Epilepsy Antiepileptic
Marijuana Compounds: A Non-Conventional Therapeutic Approach to Epilepsy in Children
Bone diseases Stimulate Bone growth
Edible Marijuana: A New Frontier in the Culinary World
Cancer Anticancer
Cannabidiol as potential anticancer drug
Chronic Diseases Cerebroprotective
Therapeutic Potential of Non-Psychotropic Cannabidiol in Ischemic Stroke
Hypertension Antihypertension
Is the cardiovascular system a therapeutic target for cannabidiol?
Intestinal prokinetic Antiprokinetic
Edible Marijuana: A New Frontier in the Culinary World
Neurodegenerative Disorders Neuroprotective
Cannabidiol for neurodegenerative disorders: Important new clinical applications for this phytocannabinoid?
Psoriasis Antipsoriatic
Edible Marijuana: A New Frontier in the Culinary World
A Critical Review of the Antipsychotic Effects of Cannabidiol: 30 Years of a Translational Investigation
Spasticity Antispasticity
Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review
Breast cancer Antiproliferative
The endocannabinoid system and cancer: Therapeutic implication
ALS Neuroprotective
Can cannabinoids be a potential therapeutic tool in amyotrophic lateral sclerosis?
Bone Diseases Stimulate Bone Growth
Role of cannabinoids in the regulation of bone remodeling
Glaucoma Antiglaucoma
Cannabinoids and glaucoma
Osteoporosis Stimulate Bone Growth
Role of cannabinoids in the regulation of bone remodeling
Anorexia Stimulate appetite
The cancer cachexia syndrome
Bipolar Neuroprotective
Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential
Bone Diseases Stimulate Bone Growth
Role of cannabinoids in the regulation of bone remodeling
Crohn’s disease Antiinflammatory
Cannabis Finds Its Way into Treatment of Crohn’s Disease
Migraine Neuroprotective
Cannabis for migraine treatment: the once and future prescription? An historical and scientific review
Osteoporosis Stimulate Bone Growth
Role of cannabinoids in the regulation of bone remodeling
Spasm and pain Antispasmodic
Prescribing Cannabinoids for Multiple Sclerosis
Bone Diseases Bone Stimulant
Role of cannabinoids in the regulation of bone remodeling
Pain Analgesic
Are cannabidiol and Δ9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review